Trials / Unknown
UnknownNCT03798028
The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis
The Effects and Safety of Mesenchymal Stem Cells in the Treatment of Moderate/Severe Rheumatoid Arthritis， a Multicenter Randomized Controlled Clinical Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the safety and therapeutic effects of single-dose human umbilical cord blood mesenchymal stem cells (UC-MSCs) on the adult patients with moderate/severe Rheumatoid Arthritis accompany with anemia or/and Interstitial pulmonary disease. Half of participants will receive UC-MSCs and keep the present medication,while the other half will receive a placebo and keep the present medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | UC-MSCs | The UC-MSCs will be administrated by intravenous injection at the dose of 1×10\^6 cells/kg. |
Timeline
- Start date
- 2017-12-26
- Primary completion
- 2019-12-31
- Completion
- 2020-06-30
- First posted
- 2019-01-09
- Last updated
- 2019-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03798028. Inclusion in this directory is not an endorsement.